-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Repare Therapeutics Announces Acquisition of Pol ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

Dow Jones·12/24/2025 12:00:00

登录查看新闻详情